Deoxynivalenol: Rationale for development and application of a urinary biomarker

Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment

Volumn 25, Issue 7, 2008, Pages 864-871

  Turner, Paul C ^a   Burley, Victoria J ^a   Rothwell, Joseph A ^a   White, Kay L M ^a   Cade, Janet E ^a   Wild, Christopher P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Biomarker; Deoxynivalenol; Diet; Mycotoxin; Urine

Indexed keywords

BIOLOGICAL MARKER; MYCOTOXIN; VOMITOXIN; CARBON 13;

ACCURACY; ARTICLE; BARLEY; CEREAL; CORN; FOOD ANALYSIS; FOOD CONTAMINATION; FOOD INTAKE; FOOD POISONING; FUSARIUM; GASTROENTERITIS; GROWTH DISORDER; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOPATHOLOGY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; STANDARD; UNITED KINGDOM; URINALYSIS; WHEAT; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TOXIN ANALYSIS;

ANIMALIA; FUSARIUM; HORDEUM; TRITICUM AESTIVUM; ZEA MAYS;

BIOLOGICAL MARKERS; CEREALS; CHROMATOGRAPHY, LIQUID; FOOD CONTAMINATION; FUSARIUM; HUMANS; MASS SPECTROMETRY; MYCOTOXINS; STATISTICS AS TOPIC; TRICHOTHECENES;

EID: 46349085112     PISSN: 19440049     EISSN: 19440057     Source Type: Journal    
DOI: 10.1080/02652030801895040     Document Type: Article

References (50)

1. Bhat, RV, Beedu, SR, Ramakrishna, Y, and Munshi, KL. 1989. Outbreak of trichothecenes mycotoxicosis associated with consumption of mould-damaged wheat production in Kashmir Valley, India. Lancet, 1:35–37.
2. Bondy, GS, and Pestka, JJ. 2000. Immunomodulation by fungal toxins. J Toxicol Environ Health B Crit Rev, 3:109–143.
3. Canady, RA, Coker, RD, Egan, SK, Krska, R, Kuiper-Goodman, T, Olsen, M, Pestka, J, Resnik, S, and Schlatter, J. 2001. Deoxynivalenol, 420–529. Geneva:Safety evaluation of certain mycotoxins in food. World Health Organization
4. CAST Potential economic costs of mycotoxins in the United States. 2003. Mycotoxins:Risks in plant, animal, and human systems, Task Force Report No. 139 136–142. Ames IA:Council for Agriculture, Science and Technology.
5. Cote, LM, Dahlem, AM, Yoshizawa, T, Swanson, SP, and Buck, WB. 1986. Excretion of deoxynivalenol and its metabolite in milk, urine, and feces of lactating dairy cows. J Dairy Sci, 69:2416–2423.
6. Creppy, EE. 2002. Update of survey, regulation and toxic effects of mycotoxins in Europe. Toxicol Lett, 127:19–28.
7. Cirilloy, T, Ritieniy, A, Galvanoz, F, and Amodio-Cocchieriy, R. 2003. Natural co-occurrence of deoxynivalenol and fumonisins B1 and B2 in Italian marketed foodstuffs. Food Addit Contam, 20:566–571.
8. Gong, Y, Torres-Sanchez, L, Lopez-Carrillo, L, Peng, JH, Sutcliffe, AE, White, KLM, Turner, PC, Humpf, H, and Wild, CP. 2008. Detection of fumonisin B1 in Mexican urine samples using liquid chromatography-mass spectrometry:A possible biomarker of dietary fumonisin exposure. Cancer Epidemiol Biomarkers Prev
9. Goyarts, T, and Danicke, S. 2006. Bioavailability of the Fusarium toxin deoxynivalenol (DON) from naturally contaminated wheat for the pig. Toxicol Lett, 163:171–182.
10. Goyarts, T, Danicke, S, Rothkotter, HJ, Spilke, J, Tiemann, U, and Schllenberger, M. 2005. On the effects of a chronic deoxynivalenol intoxication on performance, haematological and serum parameters of pigs when diets are offered either for ad libitum consumption or fed restrictively. J Vet Med A Physiol Pathol Clin Med, 52:305–314.
11. Gray, JS, and Pestka, JJ. 2007. Transcriptional regulation of deoxynivalenol-induced IL-8 expression in human monocytes. Toxicol Sci, 99:502–511.
12. Groopman, JD, Jackson, PE, Turner, PC, Wild, CP, and Kensler, TW. 2002. “ Validation of exposure and risk biomarkers:aflatoxin as a case study ”. In Biomarkers of environmentally associated disease, Edited by:Wilson, SH, and Suk, WA. 307–318. Boca Raton, FL:CRC Press.
13. Groopman JD. Johnson, D, and Kensler, T. 2005. Aflatoxin and hepatitis B virus biomarkers:A paradigm for complex environmental exposures and cancer risk. Cancer Biomarkers, 1:5–14.
14. Henderson, L, Gregory, J, and Swan, G. 2002. The National Diet and Nutrition Survey:adults aged 19 to 64 years, HMSO:Norwich. Available:http://www.food.gov.uk/multimedia/pdfs/ndnsprintedreport.pdf. Accessed:5 October 2007
15. Jackson, LS, and Bullerman, LB. 1999. Effect of processing on Fusarium mycotoxins. Adv Exp Med Biol, 459:243–261.
16. Jelinek, CF, Pohland, AE, and Wood, GE. 1989. Worldwide occurrence of mycotoxins in foods and feeds. An update. J Assoc Off Anal Chem, 72:223–230.
17. Lattanzio, VM, Solfrizzo, M, Powers, S, and Visconti, A. 2007a. Simultaneous determination of aflatoxins, ochratoxin A and Fusarium toxins in maize by liquid chromatography/tandem mass spectrometry after multitoxin immunoaffinity cleanup. Rapid Commun Mass Spectrom, 21:3253–3261.
18. Lattanzio, VM, Solfrizzo, M, and Visconti, A. 2007b. Determination of trichothecenes in cereals and cereal-based products by liquid chromatography–tandem mass spectrometry. Food Addit Contam, In press (Epublished ahead of print)
19. Li, F, Luo, X, and Yoshizawa, T. 1999. Mycotoxins (trichothecenes, zearalenone and fumonisins) in cereals associated with human red mold intoxications stored since 1989 and 1991 in China. Nat Toxins, 7:93–97.
20. Luo, X. 1994. Food poisoning caused by Fusarium toxins, 129–136. Proceedings of the 2nd Asian Conference on Food Safety.
21. Luo, Y, Yoshizawa, T, and Katayama, T. 1990. Comparative study on the natural occurrence of Fusarium mycotoxins (trichothecenes and zearalenone) in corn and wheat from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol, 56:3723–3726.
22. Meky, FA, Hardie, LJ, Evans, SW, and Wild, CP. 2001. Deoxynivalenol-induced immunomodulation of human lymphocyte proliferation and cytokine production. Food Chem Toxicol, 39:827–836.
23. Meky, FA, Turner, PC, Ashcroft, AE, Miller, JD, Qiao, Y-L, Roth, MJ, and Wild, CP. 2003. Development of a urinary biomarker of human exposure to deoxynivalenol. Food Chem Toxicol, 41:265–273.
24. Miller, JD. 1995. Fungi and mycotoxins in grain:Implications for stored product research. J Stored Prod Res, 31:1–16.
25. Montesano, R, Hainaut, P, and Wild, CP. 1997. Hepatocellular carcinoma:From gene to public health. J Natl Cancer Inst, 89:1844–1851.
26. Office for National Statistics. 2005. “ Social and Vital Statistics Division and Food Standards Agency ”. In National Diet and Nutrition Survey:Adults Aged 19 to 64 Years, Colchester:UK Data Archive. Essex SN:5140 2000–2001
27. Pestka, JJ. 2003. Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions. Toxicol Lett, 140–141:287–95.
28. Pestka, JJ, and Smolinski, AT. 2005. Deoxynivalenol:Toxicology and potential effects on humans. J Toxicol Environ Health B Crit Rev, 8:39–69.
29. Pestka, JJ, Zhou, HR, Moon, Y, and Chung, YJ. 2004. Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes:Unraveling a paradox. Toxicol Lett, 153:61–73.
30. Prelusky, DB. 1997. Effect of intraperitoneal infusion of deoxynivalenol on feed consumption and weight gain in the pig. Nat Toxins, 5:121–125.
31. Prelusky, DB, Trenholm, HL, Lawrence, GA, and Scott, PM. 1984. Nontransmission of deoxynivalenol (vomitoxin) to milk following oral administration to dairy cows. J Environ Sci Health B, 19:593–609.
32. Prelusky, DB, Veira, DM, Trenholm, HL, and Hartin, KE. 1986. Excretion profiles of the mycotoxin deoxynivalenol, following oral and intravenous administration to sheep. Fundam Appl Toxicol, 6:356–363.
33. Prelusky, DB, Hartin, KE, Trenholm, HL, and Miller, JD. 1988. Pharmacokinetic fate of 14C-labeled deoxynivalenol in swine. Fundam Appl Toxicol, 10:276–286.
34. Rotter, BA, Prelusky, DB, and Pestka, JJ. 1996. Toxicology of deoxynivalenol (vomitoxin). J Toxicol Environ Health, 48:1–34.
35. SCF Opinion of the Scientific Committee on Food on Fusarium toxins. Part 6. 2002. Group evaluation of T-2 toxin, HT-2 toxin, nivalenol and deoxynivalenol:SCF/CS/CNTM/MYC/27 Final, Available:http://europa.eu.int/comm/food/fs/sc/scf/out123_en.pdf. Accessed:5 October 2007
36. Schlatter, J. 2004. Toxicity data relevant for hazard characterization. Toxicol Lett, 153:83–9.
37. SCOOP. 2003. Collection of occurrence data of Fusarium toxins in food and assessment of dietary intake by the population of EU member states. SCOOP Task 3.2.10 Final Report, Available:http://europa.eu.int/comm/food/fs/scoop/task3210.pdf. Accessed:5 October 2007
38. Speijers, GJA, and Speijers, MHM. 2004. Combined toxic effects of mycotoxins. Toxicol Lett, 153:91–8.
39. Sundstol-Eriksen, G, and Pettersson, H. 2003. Lack of de-epoxidation of type B trichothecenes in incubates with human faeces. Food Addit Contam, 20:579–582.
40. Sugita-Konishi, Y, Park, BJ, Kobayashi-Hattori, K, Tanaka, T, Chonan, T, Yoshikawa, K, and Kumagai, S. 2006. Effect of cooking process on the deoxynivalenol content and its subsequent cytotoxicity in wheat products. Biosci Biotechnol Biochem, 70:1764–1768.
41. Tiemann, U, Bruusow, KP, Jonas, L, Pohland, R, Schneider, F, and Danicke, S. 2006. Effects of diets with cereal grains contaminated by graded levels of two Fusarium toxins on selected immunological and histological measurements in the spleen of gilts. J Anim Sci, 84:236–245.
42. Turner, PC, Nikiema, P, and Wild, CP. 1999. Fumonisin Contamination of food:Progress in development of biomarkers to better assess human health. Mutat Res, 443:81–93.
43. Turner, PC, Burley, VJ, Rothwell, JA, White, KLM, Cade, JE, and Wild, CP. 2007. Dietary wheat reduction decreases the level of urinary deoxynivalenol in UK adults. J Expos Sci Environ Epidemiol, (Epub on line doi:10.1038/sj.jes.7500611)
44. Turner, PC, Rothwell, JA, White, KLM, Cade, JE, and Wild, CP. 2008. Cereal intake is correlated with urinary deoxynivalenol in individuals from the UK. Environ Health Perspect, 36:1119–1125.
45. WHO. 1990. “ Selected Mycotoxins ”. In Ochratoxin, Tricothecenes, Ergot, Environmental Health Criteria No. 105 Geneva:WHO.
46. Wild, CP, and Turner, PC. 2001. “ Exposure biomarkers in chemoprevention studies of liver cancer ”. In Biomarkers in cancer chemoprevention. IARC Scientific Publications No.154, Edited by:Miller, AB, Bartsch, H, Bofetta, P, Dragsted, L, and Vanio, H. 215–222. Lyon, France:International Agency for Research on Cancer.
47. Wild, CP, and Turner, PC. 2002. The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis, 17:471–481.
48. Wild, CP, Andersson, C, O’Brian, NM, Wilson, L, and Woods, JA. 2001. A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. Br J Nutr, 86 (Suppl 1):S37–S53.
49. Wild, CP, Hudson, GJ, Sabbioni, G, Chapot, B, Hall, AJ, Wogan, GN, Whittle, H, Montesano, R, and Groopman, JD. 1992. Dietary intake of aflatoxins and the level of albumin-bound aflatoxin in peripheral blood in The Gambia, West Africa. Cancer Epidemiol Biomarkers Prev, 1:229–234.
50. Yoshizawa, T, Cote, LM, Swanson, SP, and Buck, WB. 1986. Confirmation of DOM-1, a de-epoxidation metabolite of deoxynivalenol in biological fluids of lactating cows. Agric Biol Chem, 50:227–229.